Talk:Tecovirimat
Appearance
This is the talk page for discussing improvements to the Tecovirimat article. This is not a forum for general discussion of the article's subject. |
Article policies
|
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
![]() | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||
|
![]() | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tecovirimat.
|
Tecovirimat may not be efficient against Clade I ?
[edit]This article from Politico seems to say that Tecovirimat is not doing much against the new clade I, and I think that should be added to the page. Can someone with more experience on the topic and on en.WP processes assess the quality of the info and add it if relevant ? (I prefer not do it myself to not cause misinformation by error) Misc (talk) 15:30, 16 August 2024 (UTC)